Pedro P. Granadillo
Senior Vice President, Eli Lilly and Company.
Companies
- Rocket Pharmaceuticals Inc.Board member Jan 16, 2018 to now1
- Orchestra BioMed Holdings, Inc.Board member Aug 3, 2020 to Aug 10, 20202
- Immunovant, Inc.Board member May 9, 2019 to May 9, 20193
- HaemoneticsBoard member May 9, 2006 to Nov 9, 20184
- NPS Pharmaceuticals (United States)Board member Nov 19, 2010 to Feb 24, 20155
- CAPRICOR THERAPEUTICS, INC.Board member Nov 1, 2007 to May 12, 20116
- Eli Lilly and CompanySenior Vice President Feb 17, 2004 to Feb 14, 20057
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY150,749 shares8$191.9M at $1,272.75Feb 14, 2005- Rocket Pharmaceuticals Inc. RCKT54,734 shares9$123.4K at $2.25Jun 18, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 18, 2025Granted 24,734 shares of Rocket Pharmaceuticals Inc.9
- Jun 18, 2025Granted 30,000 shares of Rocket Pharmaceuticals Inc.9
- Sep 23, 2004Gift 79 shares of Eli Lilly and Company8
- Sep 16, 2004Gift 16 shares of Eli Lilly and Company8
- Nov 12, 2003Gift 1 shares of Eli Lilly and Company10
- Nov 5, 2003Gift 71 shares of Eli Lilly and Company10
- Jul 28, 2003Gift 75 shares of Eli Lilly and Company10
- Jun 19, 2003Gift 123 shares of Eli Lilly and Company10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARImmunovant, Inc., Board member
- 4SEC EDGARHaemonetics, Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 5 filed Feb 17, 2004